» Articles » PMID: 21519910

Evaluation of Oxidative Status in Patients with Hyperthyroidism

Overview
Journal Endocrine
Specialty Endocrinology
Date 2011 Apr 27
PMID 21519910
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Data on the antioxidant levels enzyme in patients with hyperthyroidism are limited and conflicting. Therefore, the objective of this study was to evaluate the oxidative status using an automated method in patients with hyperthyroidism. Thirty-six subjects with hyperthyroidism and 30 healthy controls were enrolled in this study. Serum oxidative status was determined via measurement of total antioxidant capacity (TAC) and total oxidant status (TOS) and calculation of oxidative stress index (OSI). Serum TAC levels were significantly lower in patients with hyperthyroidism than controls (P=0.002), while serum TOS levels and OSI values were significantly higher (P=0.008, 0.004; respectively). Serum TAC levels were correlated with TSH levels (rho=0.223, P=0.032), FT3 levels (rho=-0.434, P=0.002) and FT4 levels (rho=-0.363, P=0.003) in patients. Further, TOS levels and OSI values were correlated with TSH levels (rho=-0.245, P=0.037; rho=-0.312, P=0.011, respectively), FT3 levels (rho=0.293, P=0.017, rho=0.505, P=0.002, respectively), and FT4 levels (rho=0.302, P=0.006, rho=0.321, P=0.008, respectively) in patients. Duration of disease was significantly correlated with OSI values in patients (rho=0.420, P=0.011), while no correlation with serum TAC levels and TOS levels (P>0.05). Oxidants are increased and antioxidants are decreased in patients with hyperthyroidism; as a result, the oxidative-antioxidative balance is shifted to the oxidative side. Increased oxidative stress may play a role in the pathogenesis of hyperthyroidism. It is believed that supplementation of antioxidant vitamins such as vitamins C and E may be helpful for these patients.

Citing Articles

Mendelian Randomization Study Investigating the Causal Relationship Between Thyroid Dysfunction and Cerebral Infarction.

Li L, Leng J, Xiong H, Deng Z, Ye M, Wang H Brain Behav. 2024; 14(12):e70188.

PMID: 39663756 PMC: 11635123. DOI: 10.1002/brb3.70188.


Risk Factors for Post-Stroke Depression Following the Lifting of COVID-19 Restrictions.

Luo S, Hu X, Hong Y, Gao Y, Liu X, Peng Y Int J Gen Med. 2024; 17:3479-3491.

PMID: 39161406 PMC: 11331147. DOI: 10.2147/IJGM.S472339.


Moderation of thyroid hormones for the relationship between amyloid and tau pathology.

Byeon J, Byun M, Yi D, Jung J, Sohn B, Chang Y Alzheimers Res Ther. 2024; 16(1):164.

PMID: 39044293 PMC: 11264392. DOI: 10.1186/s13195-024-01534-4.


Puerarin inhibits inflammation and oxidative stress in female BALB/c mouse models of Graves' disease.

Ye Z, Wu H, Chen X, Xie R, Zhang D, Sun H Transl Pediatr. 2024; 13(1):38-51.

PMID: 38323179 PMC: 10839278. DOI: 10.21037/tp-23-370.


Cardiovascular and Neuronal Consequences of Thyroid Hormones Alterations in the Ischemic Stroke.

Murolo M, Di Vincenzo O, Cicatiello A, Scalfi L, Dentice M Metabolites. 2023; 13(1).

PMID: 36676947 PMC: 9863748. DOI: 10.3390/metabo13010022.


References
1.
Halliwell B . Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet. 1994; 344(8924):721-4. DOI: 10.1016/s0140-6736(94)92211-x. View

2.
Fernandez V, Llesuy S, Solari L, Kipreos K, Videla L, Boveris A . Chemiluminescent and respiratory responses related to thyroid hormone-induced liver oxidative stress. Free Radic Res Commun. 1988; 5(2):77-84. DOI: 10.3109/10715768809066914. View

3.
Paglia D, Valentine W . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70(1):158-69. View

4.
BOZHKO A, Gorodetskaia I, Solodkov A . [Restriction of stress-induced activation of lipid peroxidation by small doses of thyroid hormones]. Biull Eksp Biol Med. 1990; 109(6):539-41. View

5.
Erel O . A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004; 37(4):277-85. DOI: 10.1016/j.clinbiochem.2003.11.015. View